Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

05/15/08 Treatment Outcomes of Glioblastoma Multiforme at Community Based Teaching Hospital        

05/12/08 Transporter Inhibition Reduces Glioma-Related Brain Edema        

05/09/08 Urinary Biomarkers Show Promise in Diagnosing Brain Tumors        

05/08/08 Musella Foundation Inket Fundraiser Changes        

05/05/08 Modulatory effects of acetazolomide and dexamethasone on temozolomide mediated apoptosis in human glioblastoma T98G and U87MG cells.        

05/05/08 Safety of anticoagulation use and bevacizumab in patients with glioma        

05/05/08 Oncothyreon files investigational new drug application for PX-866 oncology compound        

05/04/08 Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.        

05/04/08 Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival.        

05/03/08 Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas.        

05/03/08 Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.        

04/27/08 Cancer researchers receive NIH grant to advance brain tumor therapies from lab to clinical trials        

04/27/08 Experimental vaccine offers hope against brain cancer        

04/27/08 Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research        

04/27/08 New Therapies Could Change Cancer Treatment Strategies        

04/27/08 Improving quality of life for brain tumor patients        

04/27/08 Brain tumor treatment uses radiation and gene therapy        

04/27/08 Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker.        

04/27/08 Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.        

---

Displaying Stories 3690 to 3709 of 7806
Previous 20           Next 20